NIH-funded research R03 grant

How common gut bacteria may stop C. difficile from making spores

Official title: Contact-dependent suppression of Clostridioides difficile sporulation by enterococci

Funded at Albany Medical College · NIH-11457572 · Data updated 2026-11-12

This project looks at whether common gut bacteria called enterococci can stop C. difficile from making hardy spores that spread infection, which could help people prone to C. difficile infections.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionAlbany Medical College
NIH-funded
Lab location1 site (Albany, United States)
Project startMay 23, 2024
Project endMarch 31, 2027
Funding year2025
Award (this year)$75,653
NIH project number7R03AI180614-03
Project IDNIH-11457572 on NIH RePORTER

Who could benefit from this research

Could help

People who have had C. difficile infections, especially those with recurrent infections or who are at high risk after antibiotics or hospitalization, are the population most likely to benefit from treatments arising from this research.

Less likely to help

Patients with unrelated gut conditions or those needing immediate clinical treatment for severe, active C. difficile infection are unlikely to receive direct benefit from this lab-focused project.

What this research studies

From a patient's point of view, scientists will study how enterococci and C. difficile interact in the lab to see if close contact prevents C. difficile from forming spores. They will screen many enterococci mutants to find the bacterial genes and surface proteins responsible for this suppression. The team will use co-culture assays and genetic and transcriptional analyses to map how these interactions work. The experiments are lab-based using bacterial cultures and models, aimed at finding targets for treatments that limit C. difficile spread.

Why it matters

Potential benefit: If successful, this work could lead to new therapies or microbiome-based approaches that prevent C. difficile from forming spores and reduce infections and recurrences.

How similar studies have gone: Restoring healthy gut bacteria (for example with fecal microbiota transplant) has helped prevent C. difficile, but the specific contact-dependent suppression mechanism studied here is relatively novel.

Where this research is happening

  • Albany Medical College
    Albany, United States
    Active

Researchers

  • Principal investigator: Mckenney, Peter T — Albany Medical College
  • Study coordinator: Mckenney, Peter T

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.